Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Susceptible alleles of the CD40 and CTLA-4 genes are not associated with the relapse after antithyroid withdrawal in Graves' disease.

Thyroid : official journal of the American Thyroid Association - 1 Dec 2007

Kim Kyung Won, Park Young Joo, Kim Tae Yong, Park Do Joon, Park Kyong Soo, Cho Bo Youn

Abstract excerpt

In this study, we investigated whether the CD40 or cytotoxic T lymphocyte-associated molecules-4 (CTLA-4) polymorphisms, which are associated with the susceptibility of Graves' disease (GD), can predict the clinical outcome after antithyroid drug (ATD) withdrawal. All patients with GD were treated with ATD. GD patients were divided into two groups: remission or failure. The remission group was defined as patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Antigens, Differentiation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to CD40 Antigens

Share to CTLA-4 Antigen

Share to Graves Disease

Share to Propylthiouracil

Share to Recurrence

Share to Treatment Outcome

Source

Identifiers

PMID: 17949264
DOI: 10.1089/thy.2007.0011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Susceptible alleles of the CD40 and CTLA-4 genes are not associated with the relapse after antithyroid withdrawal in Graves' disease.PMID 17949264Read ↗

Cytotoxic T lymphocyte-associated molecule-4 polymorphism and relapse of Graves' hyperthyroidism after antithyroid withdrawal.Semantic proximity Read ↗

Genotype and Phenotype Predictors of Relapse of Graves’ Disease after Antithyroid Drug WithdrawalSemantic proximity Read ↗

A C/T polymorphism in CD40 gene is not associated with susceptibility and phenotype of Graves' disease in Taiwanese.Semantic proximity Read ↗

The predictive value of CTLA-4 and Tg polymorphisms in the recurrence of Graves' disease after antithyroid withdrawal.Semantic proximity Read ↗

The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.Semantic proximity Read ↗

Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene.Semantic proximity Read ↗

Cytotoxic T lymphocyte-associated molecule-4 gene polymorphism and hyperthyroid Graves' disease relapse after antithyroid drug withdrawal: a follow-up study.Semantic proximity Read ↗

Genetic markers in diagnosis and prediction of relapse in Graves' disease.Semantic proximity Read ↗

Association of an A/C single nucleotide polymorphism in programmed cell death-ligand 1 gene with Graves' disease in Japanese patients.Semantic proximity Read ↗

Recurrence of Graves' Disease: What Genetics of HLA and PTPN22 Can Tell Us.Semantic proximity Read ↗

Association of polymorphism at position 49 in exon 1 of the cytotoxic T-lymphocyte-associated factor 4 gene with Graves' disease refractory to medical treatment, but not with amiodarone-associated thyroid dysfunction.Semantic proximity Read ↗

The T393C polymorphism of the Galphas gene (GNAS1) is associated with the course of Graves' disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.